Ajmalicine, or ?-yohimbine or raubasine, is an antihypertensive drug used in the treatment of high blood pressure. It has been marketed under numerous brand names, including Card-Lamuran, Circolene, Cristanyl, Duxil, Duxor, Hydroxysarpon, Iskedyl, Isosarpan, Isquebral, Lamuran, Melanex, Raunatin, Saltucin Co, Salvation, and Sarpan.
MARKET DYNAMICS
The raubasine market is fueling due to the growing prevalence of chronic diseases and rising geriatric population. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research funding drive the growth of the market for raubasine.
MARKET SCOPE
The "Raubasine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of raubasine market with detailed market segmentation by of product, and end user/application. The raubasine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in raubasine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The raubasine market is segmented on the basis of product, and end user/application. Based on product, the market is segmented as injection, tablet and other. On the basis of end user/application, the market is categorized as anti-hypertensive and other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the raubasine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The raubasine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting raubasine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the raubasine market in these regions.
MARKET PLAYERS
The report covers key developments in the raubasine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from raubasine market are anticipated to have lucrative growth opportunities in the future with the rising demand for raubasine in the global market. Below mentioned is the list of few companies engaged in the raubasine market.
The report also includes the profiles of key players in raubasine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Enrich, LLC
- Indo Phytochem Pharmaceuticals
- Johnson & Johnson Ltd.
- Merck & Co.
- Novartis AG
- Pfizer, Inc.
- Quad Life Sciences Private Limited
- Sarv Biolabs Private Limited
- Shreeji Trading Company
- Tangerine Confectionery Limited
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.